Key result
Hearing impairment has a strong genetic basis, with several myosin gene products, including MYO7A, implicated in non-syndromic hearing loss.
The text discusses the role of myosin gene mutations, specifically MYO7A, in genetic hearing impairment.
No takes yet. Share an insight, caveat, or question.
May inform genetic counseling in non-syndromic hearing loss; leaves open functional validation in larger cohorts.
V A Street (2004) conducted a review in Hearing impairment. Hearing impairment has a strong genetic basis, with several myosin gene products, including MYO7A, implicated in non-syndromic hearing loss.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: